Novozymes A/S (OTCMKTS:NVZMY) Share Price Passes Below Two Hundred Day Moving Average – Time to Sell?

Novozymes A/S (OTCMKTS:NVZMYGet Free Report)’s stock price crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $61.62 and traded as low as $59.43. Novozymes A/S shares last traded at $60.27, with a volume of 13,732 shares traded.

Analysts Set New Price Targets

Separately, Barclays raised shares of Novozymes A/S to a “strong-buy” rating in a research note on Monday, November 18th.

View Our Latest Stock Analysis on NVZMY

Novozymes A/S Price Performance

The business has a 50-day moving average of $56.75 and a 200 day moving average of $61.60. The company has a market capitalization of $28.22 billion, a PE ratio of 38.15, a P/E/G ratio of 3.87 and a beta of 0.88.

Novozymes A/S Company Profile

(Get Free Report)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

Read More

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.